Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Vo

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Exosome-primed T cell immunity is facilitated by complement activationSara Alibrandi, Angela Clemens, Yansui Li, et al.
Transplantation Direct|June 5, 2026
CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized PatientsStanley C Jordan, Sindhu Chandran, Noriko Ammerman, et al.
Transplant Immunology|December 3, 2010
Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximabShili Ge, Andy Pao, Ashley Vo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 24, 2022
Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipientsRuan Zhang, Bong-Ha Shin, Terry-Ann M Gadsden, et al.
Pediatric Transplantation|September 21, 2017
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipientsIrene K Kim, Jua Choi, Ashley Vo, et al.
Transplant Immunology|December 1, 2009
Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitizationMieko Toyoda, Andy Pao, Ashley Vo, et al.
Transplantation Proceedings|June 22, 2020
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case ReportGaurang Vaidya, Lawrence S C Czer, Jon Kobashigawa, et al.
Kidney International Reports|May 2, 2022
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney AllograftsStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Journal of the American Society of Nephrology : JASN|December 8, 2004
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trialStanley C Jordan, Dolly Tyan, Don Stablein, et al.
Journal of Immunology Research|March 8, 2017
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant RecipientsMieko Toyoda, Bong-Ha Shin, Shili Ge, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Exosome-primed T cell immunity is facilitated by complement activationSara Alibrandi, Angela Clemens, Yansui Li, et al.
Transplantation Direct|June 5, 2026
CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized PatientsStanley C Jordan, Sindhu Chandran, Noriko Ammerman, et al.
Transplant Immunology|December 3, 2010
Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximabShili Ge, Andy Pao, Ashley Vo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 24, 2022
Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipientsRuan Zhang, Bong-Ha Shin, Terry-Ann M Gadsden, et al.
Pediatric Transplantation|September 21, 2017
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipientsIrene K Kim, Jua Choi, Ashley Vo, et al.
Transplant Immunology|December 1, 2009
Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitizationMieko Toyoda, Andy Pao, Ashley Vo, et al.
Transplantation Proceedings|June 22, 2020
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case ReportGaurang Vaidya, Lawrence S C Czer, Jon Kobashigawa, et al.
Kidney International Reports|May 2, 2022
Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney AllograftsStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Journal of the American Society of Nephrology : JASN|December 8, 2004
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trialStanley C Jordan, Dolly Tyan, Don Stablein, et al.
Journal of Immunology Research|March 8, 2017
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant RecipientsMieko Toyoda, Bong-Ha Shin, Shili Ge, et al.
Pageof 7